The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 11,850.00
Ask: 12,470.00
Change: 0.00 (0.00%)
Spread: 620.00 (5.232%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK shares weaken, Tullow loses half its market cap

Mon, 09th Dec 2019 09:23

* FTSE 100, FTSE 250 down 0.1%

* Tesco outshines the main index

* Some domestic stocks gain on election optimism

* Tullow Oil plummets after co cancels dividend, CEO exits
(Adds company news items, updates share moves)

By Muvija M and Shashwat Awasthi

Dec 9 (Reuters) - London's exporter-heavy FTSE 100 inched
lower on Monday as oil majors and Asia-exposed financials fell
on China growth worries and as the pound strengthened, while a
72% slump in Tullow Oil single-handedly dragged down midcaps.

The blue-chip index was gave up 0.1%, with its
dollar earners including spirits company Diageo and
pharmaceutical giant AstraZeneca taking a hit from gains
in sterling ahead of UK general election later this week.

The FTSE 250 midcap index was also down by the same
level, with Tullow Oil recording its steepest one-day
fall since early 2004 after the oil and gas explorer scrapped
dividend and announced the exit of its CEO.

Monday's drop wiped off roughly half of Tullow's market cap,
or 1 billion pounds ($1.28 billion), as the stock tumbled to its
lowest in 15-1/2 years. Rival Premier Oil also fell 8%.

Other news-related moves saw Tesco top the bluechip
index with a 5% rise after the retailer started a review of its
operations in Thailand and Malaysia.

Helping limit losses on the midcap bourse was engineering
firm Senior Plc, which jumped 7% on news that it was
reviewing options for its aerostructures business. Marks &
Spencer added 3.5% after a double upgrade from Goldman
Sachs.

Elsewhere, China's exports in November shrank for the fourth
consecutive month, fanning worries over the impact of the
Sino-U.S. trade war on the world's second-largest economy and
overshadowing Friday's strong U.S. jobs data.

"The contrasting U.S. and Chinese data should swing the
trade negotiation pendulum back to neutral from the Chinese side
amongst the world's trade watchers," OANDA analyst Jeffrey
Halley said.

Investors were also trying to size up the chances of a new
round of U.S. tariffs on $156 billion worth of Chinese goods
from Dec. 15.

While signs of progress in the trade negotiations lifted the
FTSE 100 to its biggest one-day gain since July on Friday, the
bourse still marked its steepest weekly fall after contradictory
messages from U.S. President Donald Trump earlier on.

"More soothing noises on the negotiations emerged from
Washington D.C. on Friday, but one gets the sense that this
Sunday's next round of tariffs on China is no longer the line in
the sand it once was perceived to be," Halley said.

On Monday, some of Britain's more domestically-exposed firms
such as Lloyds and Barclays outperformed as
investors bet on the Boris Johnson-led Conservatives to win the
election this week and deliver Brexit.

"Three days to polling day and the polls are looking good
for Boris Johnson..., although the spectre of tactical voting
still lingers," Raymond James analyst Chris Bailey said.

($1 = 0.7794 pounds)

(Reporting by Muvija M and Shashwat Awasthi in Bengaluru with
additional reporting by Tanishaa Nadkar; Editing by Arun Koyyur
and Mark Heinrich)

More News
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.